Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study

Folliculitis decalvans is a chronic inflammatory skin disease leading to scarring alopecia. Management of this disabling disease is difficult and no treatment is currently approved. Current knowledge regarding the pathogenesis of folliculitis decalvans suggests the benefit of using anti-tumour necro...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Aurore Dupont, Alexia Eyraud, Brigitte Milpied, Sylvie de Bataille, Eline Cassassa, Anne-Sophie Darrigade, Thomas Barnetche, Marie-Sylvie Doutre, Bruno Matard, Marie Beylot-Barry, Julien Seneschal
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Medical Journals Sweden 2023-03-01
Ráidu:	Acta Dermato-Venereologica
Fáttát:	folliculitis decalvans infliximab adalimumab TNFα inhibitor cicatricial alopecia
Liŋkkat:	https://medicaljournalssweden.se/actadv/article/view/3713
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!